Differences in Type I Interferon Signaling Antagonism by Dengue Viruses in Human and Non-Human Primate Cell Lines

• Freddy A. Medina,

  Affiliation Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Dengue Branch, San Juan, Puerto Rico, United States of America

  ⨯
• Giselle Torres-Malavé,

  Affiliation University of Puerto Rico Medical Science Campus, Department of Microbiology & Medical Zoology, San Juan, Puerto Rico, United States of America

  ⨯
• Amanda J. Chase,

  Affiliation Mercer University School of Medicine, Division of Basic Medical Sciences, Macon, Georgia, United States of America

  ⨯
• Gilberto A. Santiago,

  Affiliation Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Dengue Branch, San Juan, Puerto Rico, United States of America

  ⨯
• Juan F. Medina,

  Affiliation Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Dengue Branch, San Juan, Puerto Rico, United States of America

  ⨯
• Luis M. Santiago,

  Affiliation Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Dengue Branch, San Juan, Puerto Rico, United States of America

  ⨯
• Jorge L. Muñoz-Jordán

  * E-mail: ckq2@cdc.gov

  Affiliation Centers for Disease Control and Prevention, Division of Vector-Borne Diseases, Dengue Branch, San Juan, Puerto Rico, United States of America

  ⨯